REG - Societe Generale SA Takeda Pharma.Co.Ltd - Form 8.3 - Takeda Pharmaceutical CO LTD

Takeda Pharmaceutical CoAnnouncement

28/08/2018 07:05

RNS Number : 8982Y
Societe Generale SA
27 August 2018
 


FORM 8.3
 
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the "Code")
 
1.         KEY INFORMATION
 



(a) Full name of discloser:


Société Générale S.A.




(b) Owner or controller of interests and short positions disclosed, if different from 1(a):
     The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named.


 
 
 




(c) Name of offeror/offeree in relation to whose relevant securities this form relates:
     Use a separate form for each offeror/offeree


Takeda Pharmaceutical CO LTD




(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:








(e) Date position held/dealing undertaken:
     For an opening position disclosure, state the latest practicable date prior to the disclosure


24/08/2018




(f)  In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
     If it is a cash offer or possible cash offer, state "N/A"


YES: Shire PLC
 



 
2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE
 
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
 
(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
 



Class of relevant security:
 


Ordinary




 
 


Interests


Short positions








Number


%


Number


%




(1) Relevant securities owned and/or controlled:


1,616,352


0.21


6,176,891


0.79




(2) Cash-settled derivatives:
 


4,915,352


0.63


2,026


0.00




(3) Stock-settled derivatives (including options) and agreements to purchase/sell:


121,500


0.02


0


0.00




 
     TOTAL:


6,653,204


0.85


6,178,917


0.79



           
All interests and all short positions should be disclosed.
 
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
 
(b)        Rights to subscribe for new securities (including directors' and other employee options)
 



Class of relevant security in relation to which subscription right exists:








Details, including nature of the rights concerned and relevant percentages:







 
 
3.         DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
 
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
 
The currency of all prices and other monetary amounts should be stated.
 
(a)        Purchases and sales



Class of relevant security


Purchase/sale


Number of securities


Price per unit
JPY




Ordinary


Purchase


500


4561




Ordinary


Purchase


6,200


4616




Ordinary


Purchase


1,700


4616




Ordinary


Purchase


900


4611




Ordinary


Purchase


400


4596




Ordinary


Purchase


100


4558




Ordinary


Purchase


1,000


4596




Ordinary


Purchase


500


4610




Ordinary


Purchase


400


4610




Ordinary


Purchase


200


4598




Ordinary


Purchase


1,000


4594




Ordinary


Purchase


300


4559




Ordinary


Purchase


1,000


4585




Ordinary


Purchase


1,000


4591




Ordinary


Purchase


1,000


4610




Ordinary


Purchase


500


4585




Ordinary


Purchase


1,000


4583




Ordinary


Purchase


1,000


4584




Ordinary


Purchase


600


4598




Ordinary


Purchase


1,000


4597




Ordinary


Purchase


500


4601




Ordinary


Purchase


400


4559




Ordinary


Purchase


600


4596




Ordinary


Purchase


100


4599




Ordinary


Purchase


2,000


4607




Ordinary


Purchase


1,300


4560




Ordinary


Purchase


500


4576




Ordinary


Purchase


1,200


4578




Ordinary


Purchase


600


4589




Ordinary


Purchase


300


4590




Ordinary


Purchase


500


4559




Ordinary


Purchase


1,500


4598




Ordinary


Purchase


800


4599




Ordinary


Purchase


1,200


4569




Ordinary


Purchase


200


4569




Ordinary


Purchase


100


4569




Ordinary


Purchase


900


4567




Ordinary


Purchase


1,200


4570




Ordinary


Purchase


1,200


4614




Ordinary


Purchase


100


4567




Ordinary


Purchase


500


4586




Ordinary


Purchase


200


4584




Ordinary


Purchase


400


4573




Ordinary


Purchase


1,200


4584




Ordinary


Purchase


900


4571




Ordinary


Purchase


1,200


4572




Ordinary


Purchase


2,200


4612




Ordinary


Purchase


1,200


4575




Ordinary


Purchase


100


4614




Ordinary


Purchase


100


4597




Ordinary


Purchase


200


4577.5




Ordinary


Purchase


700


4577




Ordinary


Purchase


1,700


4616




Ordinary


Purchase


119


4521




Ordinary


Purchase


50


4570




Ordinary


Sale


300


4596




Ordinary


Sale


1,000


4608




Ordinary


Sale


1,000


4597




Ordinary


Sale


1,000


4575




Ordinary


Sale


300


4609




Ordinary


Sale


1,000


4585




Ordinary


Sale


900


4611




Ordinary


Sale


1,500


4567




Ordinary


Sale


1,000


4609




Ordinary


Sale


2,000


4577




Ordinary


Sale


1,000


4569.5




Ordinary


Sale


100


4598




Ordinary


Sale


300


4613




Ordinary


Sale


200


4580




Ordinary


Sale


100


4580




Ordinary


Sale


100


4609




Ordinary


Sale


1,300


4592




Ordinary


Sale


2,200


4597




Ordinary


Sale


700


4598




Ordinary


Sale


300


4596




Ordinary


Sale


1,700


4596




Ordinary


Sale


2,200


4611




Ordinary


Sale


1,300


4577




Ordinary


Sale


1,300


4578




Ordinary


Sale


1,300


4579




Ordinary


Sale


100


4581




Ordinary


Sale


200


4610




Ordinary


Sale


200


4607




Ordinary


Sale


100


4608




Ordinary


Sale


200


4609




Ordinary


Sale


1,600


4606




Ordinary


Sale


1,200


4588




Ordinary


Sale


300


4597




Ordinary


Sale


200


4610.5




Ordinary


Sale


1,200


4571




Ordinary


Sale


500


4571




Ordinary


Sale


1,200


4566.5




Ordinary


Sale


100


4567




Ordinary


Sale


100


4579




Ordinary


Sale


500


4579




Ordinary


Sale


100


4579




Ordinary


Sale


5,500


4616




Ordinary


Sale


800


4613




Ordinary


Sale


41,950


4597.3897




Ordinary


Sale


29,240


4616




Ordinary


Sale


69


4574








Total Purchases


46,269












Total Sales


109,459







 
(b)        Cash-settled derivative transactions
 



Class of relevant security


Product description
e.g. CFD


Nature of dealing
e.g. opening/closing a long/short position, increasing/reducing a long/short position


Number of reference securities


Price per unit JPY




Ordinary


CFD


Increasing a long position


41,950


4597.3897



 
 (c)       Stock-settled derivative transactions (including options)
 
(i)         Writing, selling, purchasing or varying
 



Class of relevant security


Product description e.g. call option


Writing, purchasing, selling, varying etc.


Number of securities to which option relates


Exercise price per unit


Type
e.g. American, European etc.


Expiry date


Option money paid/ received per unit JPY





































 
(ii)        Exercise
 



Class of relevant security


Product description
e.g. call option


Exercising/ exercised against


Number of securities


Exercise price per unit JPY




















 
 



 
(d)        Other dealings (including subscribing for new securities)
 



Class of relevant security


Nature of dealing
e.g. subscription, conversion


Details


Price per unit (if applicable) JPY








 
 











4.         OTHER INFORMATION
 
(a)        Indemnity and other dealing arrangements
 



Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"




 
 
 



 
(b)        Agreements, arrangements or understandings relating to options or derivatives
 



Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
(i)  the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"




 
 
 



 
(c)        Attachments
 



Is a Supplemental Form 8 (Open Positions) attached?


YES



 
 



Date of disclosure:


27/08/2018




Contact name:


Olivier Vero




Telephone number:


+44 20 7676 6969



 
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
 
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk
 
 
 




SUPPLEMENTAL FORM 8 (OPEN POSITIONS)
 
DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.
Note 5(i) on Rule 8 of the Takeover Code (the "Code")
 
 
1.         KEY INFORMATION
 



Full name of person making disclosure:


SOCIETE GENERALE SA




Name of offeror/offeree in relation to whose relevant securities the disclosure relates:


Takeda Pharmaceutical CO LTD



 
2.         STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)
 
 



Class of relevant security


Product description e.g. call option


Written or purchased


Number of securities to which option or derivative relates


Exercise price per unit


Type


Expiry date




JPY


e.g. American, European etc.




Ordinary


OTC put-option


Sale


15,700


4707


European options


14/12/2018




Ordinary


OTC put-option


Sale


30,000


5075.10


European options


14/12/2018




Ordinary


OTC put-option


Sale


29,600


5073.65


European options


14/12/2018




Ordinary


OTC put-option


Sale


15,500


4491.40


European options


14/12/2018




Ordinary


OTC put-option


Sale


30,700


4533.90


European options


14/12/2018



 
 
 
3.         AGREEMENTS TO PURCHASE OR SELL ETC.
 



Full details should be given so that the nature of the interest or position can be fully understood:




 
 
 
 
 



 
It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.
 
The currency of all prices and other monetary amounts should be stated.
 
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
 
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETPGUCWRUPRGCM